Advertisement
Canada markets closed
  • S&P/TSX

    22,259.47
    +312.06 (+1.42%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CAD/USD

    0.7317
    -0.0004 (-0.06%)
     
  • CRUDE OIL

    78.90
    +0.42 (+0.54%)
     
  • Bitcoin CAD

    86,088.10
    -1,578.70 (-1.80%)
     
  • CMC Crypto 200

    1,362.00
    +49.38 (+3.76%)
     
  • GOLD FUTURES

    2,334.80
    +3.60 (+0.15%)
     
  • RUSSELL 2000

    2,060.67
    +24.95 (+1.23%)
     
  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     
  • NASDAQ futures

    18,186.25
    -9.25 (-0.05%)
     
  • VOLATILITY

    13.49
    0.00 (0.00%)
     
  • FTSE

    8,213.49
    +41.34 (+0.51%)
     
  • NIKKEI 225

    38,608.52
    +372.45 (+0.97%)
     
  • CAD/EUR

    0.6791
    -0.0001 (-0.01%)
     

Stocks in play: Universal Ibogaine Inc.

Advises that it will not be closing its previously announced agreement to sell its 20-acre undeveloped island property located in Belize for $1,300,000 U.S. on June 15, as was scheduled. The Purchaser, an arms-length Belize based party, advised at completion of their due diligence period that they were not yet in a position to release the initial $20,000 U.S. non-refundable deposit, citing concerns with potential negative effects from the ongoing U.S. government’s debt ceiling issue, and its potential effect on the global economy. Universal Ibogaine Inc. shares V.IBO are trading unchanged at $0.02.

Read: